CRL
Price
$149.35
Change
-$0.90 (-0.60%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
7.39B
35 days until earnings call
TMO
Price
$467.61
Change
-$2.14 (-0.46%)
Updated
Sep 24, 12:32 PM (EDT)
Capitalization
177.38B
28 days until earnings call
Interact to see
Advertisement

CRL vs TMO

Header iconCRL vs TMO Comparison
Open Charts CRL vs TMOBanner chart's image
Charles River Laboratories International
Price$149.35
Change-$0.90 (-0.60%)
Volume$7.39K
Capitalization7.39B
Thermo Fisher Scientific
Price$467.61
Change-$2.14 (-0.46%)
Volume$1.88K
Capitalization177.38B
CRL vs TMO Comparison Chart in %
Loading...
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRL vs. TMO commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a StrongBuy and TMO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (CRL: $150.25 vs. TMO: $469.75)
Brand notoriety: CRL and TMO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CRL: 84% vs. TMO: 138%
Market capitalization -- CRL: $7.39B vs. TMO: $177.38B
CRL [@Medical Specialties] is valued at $7.39B. TMO’s [@Medical Specialties] market capitalization is $177.38B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $10.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 1 FA rating(s) are green whileTMO’s FA Score has 0 green FA rating(s).

  • CRL’s FA Score: 1 green, 4 red.
  • TMO’s FA Score: 0 green, 5 red.
According to our system of comparison, CRL is a better buy in the long-term than TMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 5 TA indicator(s) are bullish while TMO’s TA Score has 3 bullish TA indicator(s).

  • CRL’s TA Score: 5 bullish, 5 bearish.
  • TMO’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CRL is a better buy in the short-term than TMO.

Price Growth

CRL (@Medical Specialties) experienced а -0.89% price change this week, while TMO (@Medical Specialties) price change was -2.29% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.95%. For the same industry, the average monthly price growth was +3.73%, and the average quarterly price growth was +26.50%.

Reported Earning Dates

CRL is expected to report earnings on Oct 29, 2025.

TMO is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Medical Specialties (+0.95% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TMO($177B) has a higher market cap than CRL($7.39B). CRL has higher P/E ratio than TMO: CRL (577.05) vs TMO (27.17). TMO YTD gains are higher at: -9.452 vs. CRL (-18.608). TMO has more cash in the bank: 1.12B vs. CRL (183M). CRL has less debt than TMO: CRL (2.79B) vs TMO (35.2B).
CRLTMOCRL / TMO
Capitalization7.39B177B4%
EBITDA528MN/A-
Gain YTD-18.608-9.452197%
P/E Ratio577.0527.172,124%
Revenue4.03BN/A-
Total Cash183M1.12B16%
Total Debt2.79B35.2B8%
FUNDAMENTALS RATINGS
CRL vs TMO: Fundamental Ratings
CRL
TMO
OUTLOOK RATING
1..100
6352
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
68
Overvalued
PROFIT vs RISK RATING
1..100
10084
SMR RATING
1..100
9258
PRICE GROWTH RATING
1..100
6260
P/E GROWTH RATING
1..100
182
SEASONALITY SCORE
1..100
4650

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TMO's Valuation (68) in the Medical Specialties industry is in the same range as CRL (94) in the Miscellaneous Commercial Services industry. This means that TMO’s stock grew similarly to CRL’s over the last 12 months.

TMO's Profit vs Risk Rating (84) in the Medical Specialties industry is in the same range as CRL (100) in the Miscellaneous Commercial Services industry. This means that TMO’s stock grew similarly to CRL’s over the last 12 months.

TMO's SMR Rating (58) in the Medical Specialties industry is somewhat better than the same rating for CRL (92) in the Miscellaneous Commercial Services industry. This means that TMO’s stock grew somewhat faster than CRL’s over the last 12 months.

TMO's Price Growth Rating (60) in the Medical Specialties industry is in the same range as CRL (62) in the Miscellaneous Commercial Services industry. This means that TMO’s stock grew similarly to CRL’s over the last 12 months.

CRL's P/E Growth Rating (1) in the Miscellaneous Commercial Services industry is significantly better than the same rating for TMO (82) in the Medical Specialties industry. This means that CRL’s stock grew significantly faster than TMO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLTMO
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
45%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
42%
Momentum
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
53%
MACD
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 7 days ago
69%
Bullish Trend 20 days ago
61%
Declines
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
64%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPIR12.000.59
+5.17%
Spire Global
MTCH36.940.51
+1.40%
Match Group
BPOPM25.240.03
+0.12%
Popular
MAN37.33-0.50
-1.32%
ManpowerGroup
MTEN8.65-2.10
-19.53%
Mingteng International Corp

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been loosely correlated with RVTY. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CRL jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
-2.37%
RVTY - CRL
61%
Loosely correlated
-0.65%
A - CRL
58%
Loosely correlated
-0.31%
NOTV - CRL
58%
Loosely correlated
+0.71%
ICLR - CRL
58%
Loosely correlated
-0.25%
TMO - CRL
57%
Loosely correlated
-1.10%
More

TMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, TMO has been closely correlated with A. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if TMO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMO
1D Price
Change %
TMO100%
-1.10%
A - TMO
79%
Closely correlated
-0.31%
DHR - TMO
79%
Closely correlated
-0.39%
MTD - TMO
77%
Closely correlated
-0.08%
RVTY - TMO
74%
Closely correlated
-0.65%
BRKR - TMO
69%
Closely correlated
+1.77%
More